Public-domain · open source
OpenJurist

731 F.3d 751

Docket No. 11-2404.

United States v. Abrahamson

Eighth Circuit Court of Appeals

Submitted: Aug. 30, 2013.

Filed: Sept. 9, 2013.

Eighth Circuit Court of Appeals · decided 2013-09-09

Cited by 14 later decisions — most recently December 2020

8 federal appellate ·

2 counsel of record

Applies 21 U.S.C. § 841 (§ 401 of the Controlled Substances Act) · 21 U.S.C. § 846 (§ 406 of the Controlled Substances Act)

Relies on Almendarez-Torres v. United States · Alleyne v. United States · Pfizer, Inc. v. Law Offices of Peter G. Angelos

Good law ✅— No negative treatment on recordhow we know

Opinion by (per_curiam) · Decided 2013-09-09

View the full empirical analysis of this case →

¶1Scott L. Bandstra, Karmen R. Anderson, Des Moines, IA, for appellant.

¶2James M. McHugh, Spec. Asst. U.S. Atty., Des Moines, IA (Nicholas A. Kline-feldt, U.S. Atty., on the brief), for appellee.

¶3Before GRUENDER, BENTON, and SHEPHERD, Circuit Judges.

¶4PER CURIAM.

¶5Michael Byron Abrahamson was convicted of conspiracy to manufacture methamphetamine in violation of 21 U.S.C. §§ 846 and 841(a)(1). At sentencing, the district court1 found that Abrahamson had a prior felony drug conviction and applied a statutory sentencing enhancement that doubled his mandatory minimum sentence from ten years to twenty years. See 21 U.S.C. § 841(b)(1). Based oh the enhancement, the district court sentenced Abrahamson to twenty years’ imprisonment. Abraham-son appealed his conviction and sentence, arguing, inter alia, that the district court’s application of the sentencing enhancement violated the Sixth Amendment because the fact underlying the enhancement — the existence of a prior felony drug conviction— was found by the district court rather than a jury. We affirmed. See United States v. Abrahamson, 685 F.3d 777 (8th Cir.2012). On June 24, 2013, the United States Supreme Court granted certiorari, vacated the judgment, and remanded the case for further consideration in light of the Court’s decision in Alleyne v. United States, 570 U.S. -, 133 S.Ct. 2151, 186 L.Ed.2d 314 (2013). See Abrahamson v. United States, 570 U.S. -, 133 S.Ct. 2853, — L.Ed.2d-(2013).

¶6In Alleyne, the Court held that a fact that increases a defendant’s mandatory *752minimum sentence is an element of the crime that must be submitted to a jury. See 133 S.Ct. at 2155. However, the Court in Alleyne left intact the rule that enhancements based on the fact of a prior conviction are an exception to the general rule that facts increasing the prescribed range of penalties must be presented to a jury. See id. at 2160 n. 1 (explaining that because the parties did not address the recidivism enhancement exception recognized in Almendarez-Torres v. United States, 523 U.S. 224, 118 S.Ct. 1219, 140 L.Ed.2d 350 (1998), the Court would not revisit the issue). Because the challenged enhancement of Abrahamson’s sentence was based solely on his prior felony drug conviction, it continues to fall under the recidivism exception to the jury presentation requirement that the Court recognized in Almendarez-Torres and left unchanged in Alleyne. See United States v. Torres-Alvarado, 416 F.3d 808, 810 (8th Cir.2005) (“While it is unclear whether Al-mendarez-Torres and its felony exception will remain good law, we are bound by Almendarez-Torres until the Supreme Court explicitly overrules it.” (internal citation omitted)). Thus, we affirm Abra-hamson’s sentence, and we affirm Abra-hamson’s conviction for the reasons stated in our prior opinion. See Abrahamson, 685 F.3d 777.

/731/f3d/751 · .json · Public domain